One shot of high-dose amikacin: a working hypothesis.
Recent information suggests that single, large daily dosages of amikacin are less nephrotoxic. The killing rate of amikacin for Escherichia coli and Pseudomonas aeruginosa also suggests to put emphasis on a high peak value. A decrease of 3 log10 CFU/ml was observed for E. coli and P. aeruginosa at 64 and 128 micrograms/ml in 20 min. In comparison, the killing rate of piperacillin was dose-independent and about 6 h were required for a reduction of 10(3) CFU/ml of P. aeruginosa. In theory, the way to proceed in the future would possibly be the one-shot administration of amikacin, followed by a long course of a beta-lactam antibiotic.
Yourassowsky
E
E
Department of Microbiology, Brugmann University Hospital Brussels, Belgium.
Van der Linden
M P
MP
Crokaert
F
F
D000583:Amikacin / Q000008:administration & dosage* / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015169:Colony Count, Microbial; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development; D010878:Piperacillin / Q000008:administration & dosage* / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000254:growth & development; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000583:Amikacin; D010878:Piperacillin